Pelthos Therapeutics Inc. · AMEX:PTHS

Pauls Matthew sold 786 Pelthos Therapeutics Inc. shares (Form 4)

Traded Oct 2, 2026 · Filed Oct 6, 2026

On Oct 2, 2026, Pauls Matthew (Director) sold 786 Pelthos Therapeutics Inc. shares at US$21.00 for US$16,506 under a trading plan, leaving 13,578 shares. Filed Oct 6, 2026 (Form 4).

Sold
786 shares
Price
US$21.00
Value
US$16,506
Holding after
13,578 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 2, 2026Common StockSale786US$21.0013,578Direct

Source

View original at SEC

Related